The North America cystoscopes market is expected to attain US$ 207.2 Mn in 2026.  Video cystoscopes market was identified as the largest and fastest growing market during the forecast period from 2018 to 2026. The supremacy is accounted to its offered benefits of enhanced diagnostic and treatment procedures. Requirement of skilled professionals and the need for procedures to be carried out in sterile environment primarily contribute to higher adoption of cystoscopes in hospitals and thereby to their largest share in North American market. Growing awareness of cystoscopes and its ease of use, accounts for rise in its demand among ambulatory care services leading to fastest growth rate during the forecast period. As reported by Photocure ASA (February 2018), 1.2 million cystoscopies are performed annually in the U.S. This value is further expected to increase during the forecast period owing to rising prevalence of bladder cancer, bladder stones, and cystitis. The growing prevalence of urologic conditions thus catalyzes the overall market growth in North America.

Conversely, sterility of cystoscopes is a major concern, which could have a negative impact on the overall market growth. Thus arises an unmet need of disposable cystoscopes to overcome the sterility issue, which will also mitigate the burden of urethral infections. However, various manufacturers currently provide cystoscopes with disposable endosheath protective barriers that ensure minimal patient-to-device contact avoiding contamination. Of the countries analyzed, U.S. accounted for maximum market share in 2017, and expected to continueits dominance throughout the forecast period. Growing prevalence of urinary disorders, increased healthcare expenditure, continuous product development activities, and presence of leading manufacturers namely, Cogentix Medical, Inc., Olympus Corporation and many more contribute to the overall market growth in the U.S.

"Video Cystoscopes to Maintain Supremacy throughout the Forecast Period"

Video cystoscopes accounted for maximum market share in 2017 and attained fastest growth rate during the forecast period from 2018 to 2026. This trend is followed by the growth of flexible non-video cystoscopes. The use of video cystoscopes increases the efficiency of diagnostic and therapeutic procedures thus augmenting their demand. On the other hand, flexible non-video cystoscopes are comparatively lower priced and their flexible nature ensures patient comfort and less painful procedure. Additionally, newer technologies namely, Blue Light Cystoscopy with Cysview enables enhanced diagnosis of cancerous cells. The Cysview (hexaminolevulinate HCl) gets absorbed by cancerous cells and glows pink under blue light. This development has further catalyzed the video cystoscopes market growth. Additionally, growing prevalence of bladder cancer, high patient awareness coupled with uniform product accessibility, minimally invasive technique and reduced procedural time benefits, contribute to the lucrativeness of video cystoscopes.

"Hospitals Contributed Maximum to the Overall North America Cystoscopes Market in 2017"

Hospitals segment accounted for maximum market share in 2017 and continues to dominate the market throughout the forecast period; while ambulatory care centers was identified as the fastest growing market during the forecast period from 2018 to 2026. Presence of skilled professionals, ease of availability of cystoscopy techniques, suitable reimbursement benefits, and high disposable incomes are the major factors for hospitals, significantly contribute to the overall cystoscopes market growth. Rising healthcare establishments and increasing benefits for health insurance companies primarily account for the fastest growth rate of ambulatory care services during the forecast period from 2018 to 2026. According to an article published on American College of Surgeons (FACS) (2017), a shift of outpatient procedures from hospitals to ambulatory care services would save US$ 25 Bn to Medicare over 10 years.

"United States Enjoyed Supremacy in 2017 and Expected to Continues this Trend Through 2026"

United States contributed the largest market share of above 72% in 2017 and shall exhibit similar dominance through 2026. Developed healthcare infrastructure, high disposable income of patients along with supportive reimbursement policies, awareness on new technologies in cystoscopy and rising prevalence of bladder cancer & kidney stones predominantly catalyze the overall U.S. cystoscopes market growth. According to the American Cancer Society, an estimated 81,190 new cases of urinary bladder cancer are expected to be diagnosed in 2018 with 17,240 expected deaths in the same year in the United States, making bladder cancer as the fourth common cancer in the country.

The Canadian Cancer Society estimated 8,900 Canadians diagnosed with bladder cancer in 2017. The growing prevalence of urologic disorders amongst Canadian population, rising awareness about benefits of cystoscopy and development of healthcare facilities contribute to the fastest CAGR during the forecast period from 2018 to 2026.

"North America Cystoscopes Market Renders Opportunities for New and Emerging Market Players"

North America cystoscopes market encompasses few market players enjoying prominence, namely Cogentix Medical, Inc. and Olympus Corporation. Market players like Olympus Corporation and Karl Storz GmbH & Co. KG have incorporated the new Blue Light Cystoscopy technology thus gaining a competitive edge in the market. Credence Research, Inc., expects that development in disposable cystoscopes similar to disposable endoscopes could gain additional market potential owing to better cost-efficiency and reduced risk of microbial contamination. This unmet need opens opportunities for emerging market players with advanced technologies.

This report provides qualitative information for factors namely, market drivers, restraints & opportunities that would give a complete understanding of the prevalent scenario in North American cystoscopes market. Additionally, the report also includes graphical representation of competitive landscape depicting market position of key market leaders based on their market initiatives, product portfolio, financial information and business developments. Key market leaders profiled in this report are Cogentix Medical, Inc., Fujifilm Corporation, Karl Storz GmbH & Co. KG, Laborie Medical Technologies, Inc., Olympus Corporation, PENTAX Medical Company, Richard Wolf GmbH and Stryker Corporation.

Historical & Forecast Period

This study report represents analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of North America Cystoscopes market are as follows:

• Research and development budgets of manufacturers and government spending
• Revenues of key companies in the market segment
• Number of end users and consumption volume, price and value.
• Geographical revenues generate by countries considered in the report
• Micro and macro environment factors that are currently influencing the North America Cystoscopes market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Key questions answered in this report

• What are the key micro and macro environmental factors that are impacting the growth of North America Cystoscopes market?
• What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
• Estimated forecast and market projections up to 2032.
• Which segment accounts for the fastest CAGR during the forecast period?
• Which market segment holds a larger market share and why?
• Are low and middle-income economies investing in the North America Cystoscopes market?
• Which is the largest regional market for North America Cystoscopes market?
• What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
• Which are the key trends driving North America Cystoscopes market growth?
• Who are the key competitors and what are their key strategies to enhance their market presence in the North America Cystoscopes market worldwide?